V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016188 | 270008682 | 0 | 49.65 | Disease modification (D) | 2013-09-05 | 2013-09-05 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013978 | TRIAL |
| 270016189 | 270008684 | null | 34.3 | Palliative (P) | 2016-12-14 | 2016-12-29 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013981 | TRIAL |
| 270016190 | 270018244 | 0 | 58.2 | Curative (C) | 2014-07-03 | 2014-08-27 | COPP + Dacarbazine | N | N | 270013983 | COPP + DACARBAZINE |
| 270016191 | 270008687 | 0 | 57.8 | null | 2016-04-09 | 2016-04-12 | ESHAP | 2 | N | 270013991 | ESHAP |
| 270016192 | 270014103 | 1.41 | 33.3 | Curative (C) | 2017-05-15 | 2017-07-18 | CISPLATIN + RT | 02 | N | 270013992 | CISPLATIN + RT |
| 270016193 | 270008691 | 1.92 | 56.1 | null | 2017-02-20 | 2017-02-24 | HD EuroNet-PHL-C1 OEPA | N | Y | 270013997 | OEPA |
| 270016194 | 270008694 | 1.82 | 78.5 | Curative (C) | 2018-01-27 | 2018-02-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014006 | CETUXIMAB + IRINOTECAN + MDG |
| 270016195 | 270008697 | null | 45.8 | Curative (C) | 2014-12-06 | 2014-12-07 | LEAM | null | null | 270014019 | LEAM |
| 270016196 | 270008697 | 1.92 | 54.2 | Curative (C) | 2015-07-19 | 2017-01-22 | ESHAP | N | N | 270014019 | ESHAP |
| 270016197 | 270008705 | 1.85 | 65 | Curative (C) | 2015-07-17 | 2015-07-18 | OEPA | N | N | 270014084 | OEPA |
| 270016198 | 270016731 | 1.8 | 98 | Adjuvant (A) | 2014-08-16 | 2014-08-16 | HD EuroNet-PHL-C1 OEPA | N | N | 270014093 | OEPA |
| 270016199 | 270019900 | null | 108.8 | Curative (C) | 2014-03-06 | 2014-03-20 | CISPLATIN + RT | null | Y | 270014132 | CISPLATIN + RT |
| 270016200 | 270008708 | 1.61 | 84 | null | 2017-03-25 | 2017-04-08 | LEAM | 2 | N | 270014136 | LEAM |
| 270016201 | 270014114 | null | 92 | Curative (C) | 2014-02-28 | 2014-03-04 | BEAM | 01 | N | 270014163 | BEAM |
| 270016202 | 270014115 | 1.79 | 84.4 | Adjuvant (A) | null | 2014-08-08 | Rituximab | N | N | 270014168 | RITUXIMAB |
| 270016203 | 270008717 | 0 | 49.8 | Disease modification (D) | 2012-10-01 | 2013-02-11 | Rituximab | N | N | 270014176 | RITUXIMAB |
| 270016204 | 270008718 | 1.79 | 73 | Curative (C) | 2018-09-27 | 2018-10-02 | ESHAP | N | N | 270014178 | ESHAP |
| 270016205 | 270008720 | 1.87 | 92.9 | Curative (C) | 2014-09-16 | 2014-11-01 | OEPA | 99 | Y | 270014196 | OEPA |
| 270016206 | 270008728 | null | null | Curative (C) | null | 2015-03-16 | ESHAP | 02 | null | 270014220 | ESHAP |
| 270016207 | 270016738 | 1.54 | 75.9 | Curative (C) | 2013-12-29 | 2014-01-01 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014221 | CETUXIMAB + IRINOTECAN + MDG |
| 270016208 | 270014125 | 1.7 | 72 | Curative (C) | null | 2015-07-22 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270014242 | CISPLATIN + RT |
| 270016209 | 270008735 | 1.95 | null | Curative (C) | 2016-08-16 | 2016-08-30 | ESHAP | null | null | 270014243 | ESHAP |
| 270016210 | 270008739 | 1.65 | 68.1 | Curative (C) | null | 2018-01-09 | ESHAP | N | N | 270014256 | ESHAP |
| 270016211 | 270008740 | 1.75 | null | null | 2017-08-22 | 2017-08-27 | CISPLATIN + RT | 02 | N | 270014264 | CISPLATIN + RT |
| 270016212 | 270008742 | null | null | Curative (C) | 2018-08-03 | 2018-09-18 | ESHAP | 02 | null | 270014274 | ESHAP |
| 270016213 | 270008744 | 1.72 | 74.3 | Curative (C) | 2015-12-05 | 2015-12-11 | BEAM | N | N | 270014274 | BEAM |
| 270016214 | 270008747 | 1.74 | 109.7 | null | 2017-11-01 | 2017-12-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270014286 | CETUXIMAB + IRINOTECAN + MDG |
| 270016215 | 270016743 | 1.79 | 65.4 | Palliative (P) | 2014-09-09 | 2014-09-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014291 | CETUXIMAB + IRINOTECAN + MDG |
| 270016216 | 270016743 | 0 | 74.5 | Curative (C) | 2017-08-06 | 2017-08-08 | ESHAP | N | N | 270014291 | ESHAP |
| 270016217 | 270008751 | 1.79 | 81.4 | Curative (C) | null | 2014-10-19 | OEPA | 02 | Y | 270014350 | OEPA |
| 270016218 | 270008754 | 1.75 | 67.7 | null | 2015-05-13 | 2015-05-13 | Rituximab | 2 | Y | 270014354 | RITUXIMAB |
| 270016219 | 270008756 | null | 69.4 | Palliative (P) | 2013-07-31 | 2013-12-27 | Cetuximab + FOLFIRI cycle 2 onwards | null | N | 270014363 | CETUXIMAB + IRINOTECAN + MDG |
| 270016220 | 270008757 | 1.74 | 73.05 | Palliative (P) | 2013-04-09 | 2013-05-02 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014372 | CETUXIMAB + IRINOTECAN + MDG |
| 270016221 | 270016746 | 1.65 | 76.4 | Adjuvant (A) | 2013-03-02 | 2013-03-15 | Rituximab | N | Y | 270014373 | RITUXIMAB |
| 270016222 | 270008758 | 1.82 | 131.6 | Disease modification (D) | null | 2015-11-04 | Rituximab | 02 | N | 270014374 | RITUXIMAB |
| 270016223 | 270008760 | 1.73 | 78 | Adjuvant (A) | 2015-08-25 | 2015-08-26 | OEPA | N | N | 270014375 | OEPA |
| 270016224 | 270008760 | 0 | 30.9 | Curative (C) | 2015-07-27 | 2015-07-31 | Cisplatin + Radiotherapy | N | N | 270014375 | CISPLATIN + RT |
| 270016225 | 270008760 | 1.78 | 74.4 | Curative (C) | 2013-02-17 | 2013-03-30 | Cisplatin + Radiotherapy | N | N | 270014375 | CISPLATIN + RT |
| 270016226 | 270014138 | 1.71 | 60 | Curative (C) | 2014-10-21 | 2014-12-03 | Cisplatin 100 + RT(H&N) 1 day | N | null | 270014386 | CISPLATIN + RT |
| 270016227 | 270019620 | 1.56 | 77.3 | Palliative (P) | 2017-09-06 | 2017-09-06 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014390 | CETUXIMAB + IRINOTECAN + MDG |
| 270016228 | 270020057 | 1.68 | 115.5 | Disease modification (D) | 2016-10-12 | 2016-10-25 | BEAM | 2 | N | 270014392 | BEAM |
| 270016229 | 270008763 | null | 99 | Curative (C) | 2017-04-24 | 2017-05-21 | LEAM | 02 | N | 270014393 | LEAM |
| 270016230 | 270016749 | 1.74 | 54.2 | Palliative (P) | 2016-10-17 | 2016-11-09 | CETUXIMAB + IRINOTECAN + MDG | N | null | 270014396 | CETUXIMAB + IRINOTECAN + MDG |
| 270016231 | 270008764 | null | 40.8 | Curative (C) | 2013-10-14 | 2013-10-20 | BEAM | N | Y | 270014396 | BEAM |
| 270016232 | 270008765 | 1.77 | 17 | Disease modification (D) | 2016-01-29 | 2016-01-29 | Rituximab | 02 | N | 270014405 | RITUXIMAB |
| 270016233 | 270008767 | 1.72 | 129.8 | Curative (C) | 2017-11-27 | 2017-12-06 | OEPA | 02 | N | 270014409 | OEPA |
| 270016234 | 270008771 | null | 0 | null | 2016-11-24 | 2016-12-05 | Cisplatin + Radiotherapy | null | null | 270014411 | CISPLATIN + RT |
| 270016235 | 270008774 | null | 77.8 | Curative (C) | 2018-02-12 | 2018-02-12 | ESHAP | 2 | N | 270014412 | ESHAP |
| 270016236 | 270008776 | 1.84 | 50.9 | null | null | 2017-05-29 | Rituximab | N | N | 270014414 | RITUXIMAB |
| 270016237 | 270008780 | 1.84 | 70.9 | Palliative (P) | 2015-08-29 | 2015-09-04 | Cetuximab + FOLFIRI cycle1 | N | N | 270014418 | CETUXIMAB + IRINOTECAN + MDG |